Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrogen Bromide | HCID 260 | — |
| Reactant | HCID 25164163 | HCID 25164163 | — |
| Solvent | Isopropanol | HCID 3776 | — |
| Product | HCID 25255742 | HCID 25255742 | — |
Reaction Steps
300 mg ethyl 4-[4-[(2R)-3-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-1-oxo-2-[[[4-(1,2,4,5-tetrahydro-2-oxo-3H-1,3-benzodiazepin-3-yl)-1-piperidinyl]carbonyl]oxy]propyl]-1-piperazinyl]-piperidine-1-acetate (0.379 mmol) of are dissolved in 3 ml isopropanol at ambient temperature and combined with 75.4 μL hydrobromic acid (30% in glacial acetic acid, 0.379 mmol), whereupon a sticky precipitate is immediately formed. The suspension is heated to 100° C., whereupon the precipitate formed goes back into solution. The solution is slowly cooled to ambient temperature. The solid formed is filtered off, washed with a little isopropanol and dried for 12 hours at 40° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08551987B2 |
|---|
| Source dataset | uspto-grants-2013_10 |
|---|
| ORD ID | ord-abbdad707426405f91493be8d17f68a0 |
|---|
| Source note | uspto-grants-2013_10 |
|---|